BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 14, 2014
View Archived Issues
ArmaGen Technologies' re-engineered IDS penetrates BBB
Read More
Protalix BioTherapeutics presents new preclinical data on PRX-102
Read More
Catalent forms regenerative therapy agreement with Kyoto University
Read More
Proteostasis Therapeutics presents data on novel USP14 inhibitor
Read More
Medinet establishes partnership with TC BioPharm for immuno-cell product
Read More
AstraZeneca and Osaka University to collaborate on repurposing drugs for cardiovascular disease
Read More
Purdue Pharma reports phase III data for once-daily hydrocodone bitartrate
Read More
Formycon advances biosimilar pipeline
Read More
Gilead Sciences plans phase I study of GS-5745 in COPD
Read More
Peregrine Pharmaceuticals' PS-targeted programs supported by recent preclinical data
Read More
Pluristem Therapeutics reports preclinical data on PLX-PAD cells for tendon injury
Read More
Progression-free survival improved with fosbretabulin added to bevacizumab in ovarian cancer
Read More
GSK reports phase III data for mepolizumab in severe eosinophilic asthma
Read More
Researchers identify a new putative compensatory mechanism of miR1246 in colorectal cancer
Read More
JDP Therapeutics receives FDA clearance for phase III trial of JDP-205 in acute urticaria
Read More
GlaxoSmithKline and Theravance complete enrollment in SUMMIT study
Read More
Novartis discloses new mGlu5 receptor antagonists
Read More
Favorable 24-week virological efficacy of BMS-663068 supports continued development
Read More
GlaxoSmithKline patent reports new anti-LRP-6 antibodies
Read More
Daiichi Sankyo designs new chromone derivatives for osteoporosis and bone fractures
Read More
Potent antiviral activity and favorable safety of doravirine in HIV-1-infected patients
Read More
Idera plans to initiate clinical development of IMO-8400 in two new indications
Read More
GSK-744/rilpivirine as maintenance therapy for HIV infection
Read More
High early bactericidal activity of pretomanid combined with bedaquiline and pyrazinamide
Read More
Knopp enters new NIAID collaboration to investigate eosinophil-lowering effects of dexpramipexole
Read More
FDA accepts Envarsus NDA for review
Read More
Novartis' Bexsero obtains clinical recommendation in Australia
Read More